Clinical Research Directory
Browse clinical research sites, groups, and studies.
Multicenter Randomized Trial of 68Ga-PSMA-11 PET/CT Based SRT After Radical Prostatectomy
Sponsor: Jonsson Comprehensive Cancer Center
Summary
This phase III trial studies how well Gallium Ga 68-labeled PSMA-11 (68Ga-PSMA-11) positron emission tomography (PET)/computed tomography (CT) works in diagnosing participants with prostate cancer that has come back after surgery. 68Ga-PSMA-11 are taken up by cancer cells. Diagnostic procedures, such as PET/CT scans, may help find and diagnose prostate cancer and find out how far the disease has spread. Giving 68Ga-PSMA-11 with PET/CT may help doctors plan better for salvage radiation therapy in participants with recurrent prostate cancer.
Official title: Phase III Randomized Multicenter Trial of 68Ga-PSMA-11 PET/CT Molecular Imaging for Prostate Cancer Salvage Radiotherapy Planning [PSMA-SRT]
Key Details
Gender
MALE
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
193
Start Date
2018-07-12
Completion Date
2027-07-12
Last Updated
2025-05-13
Healthy Volunteers
No
Conditions
Interventions
Best Practice
Undergo standard of care
Computed Tomography
Undergo PET/CT
Gallium Ga 68-labeled PSMA-11
Given IV
Positron Emission Tomography
Undergo PET/CT
Locations (2)
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States
UCSF Medical Center-Mount Zion
San Francisco, California, United States